Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
Angle Orthod ; 84(3): 492-9, 2014 May.
Article in English | MEDLINE | ID: mdl-24219652

ABSTRACT

OBJECTIVE: To quantify smile esthetics following orthodontic treatment and determine whether these changes are correlated to the severity of the initial malocclusion. MATERIALS AND METHODS: A standardized smile mesh analysis that evaluated nine lip-tooth characteristics was applied to two groups of successfully treated patients: group 1 (initial American Board of Orthodontics Discrepancy Index [DI] score<20) and group 2 (initial DI score>20). T-tests were used to detect significant differences between the low-DI and high-DI groups for baseline pretreatment measurements, baseline posttreatment measurements, and changes from pre- to posttreatment. A Spearman correlation test compared the initial DI values with the changes in the nine smile measurements. RESULTS: Five of the smile measurements were improved in both groups following orthodontic treatment. Both groups demonstrated improved incisor exposure, an improved gingival smile line, an increase in smile width, a decreased buccal corridor space, and an improvement in smile consonance. Spearman correlation tests showed that initial DI value was not correlated to changes in any of the individual smile measurements. CONCLUSIONS: Smile esthetics is improved by orthodontic treatment regardless of the initial severity of the malocclusion. In other words, patients with more complex orthodontic issues and their counterparts with minor malocclusions benefitted equally from treatment in terms of their smile esthetics.


Subject(s)
Esthetics, Dental , Malocclusion/therapy , Smiling , Cheek/anatomy & histology , Female , Follow-Up Studies , Gingiva/anatomy & histology , Humans , Incisor/anatomy & histology , Lip/anatomy & histology , Male , Photography, Dental , Retrospective Studies
3.
Vet Clin Pathol ; 41(4): 441-53, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23240820

ABSTRACT

Reference intervals (RI) are an integral component of laboratory diagnostic testing and clinical decision-making and represent estimated distributions of reference values (RV) from healthy populations of comparable individuals. Because decisions to pursue diagnoses or initiate treatment are often based on values falling outside RI, the collection and analysis of RV should be approached with diligence. This report is a condensation of the ASVCP 2011 consensus guidelines for determination of de novo RI in veterinary species, which mirror the 2008 Clinical Laboratory and Standards Institute (CLSI) recommendations, but with language and examples specific to veterinary species. Newer topics include robust methods for calculating RI from small sample sizes and procedures for outlier detection adapted to data quality. Because collecting sufficient reference samples is challenging, this document also provides recommendations for determining multicenter RI and for transference and validation of RI from other sources (eg, manufacturers). Advice for use and interpretation of subject-based RI is included, as these RI are an alternative to population-based RI when sample size or inter-individual variation is high. Finally, generation of decision limits, which distinguish between populations according to a predefined query (eg, diseased or non-diseased), is described. Adoption of these guidelines by the entire veterinary community will improve communication and dissemination of expected clinical laboratory values in a variety of animal species and will provide a template for publications on RI. This and other reports from the Quality Assurance and Laboratory Standards (QALS) committee are intended to promote quality laboratory practices in laboratories serving both clinical and research veterinarians.


Subject(s)
Clinical Laboratory Techniques/standards , Laboratories/standards , Veterinary Medicine/standards , Animals , Reference Values
4.
Vet Clin Pathol ; 41(1): 18-26, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22390424

ABSTRACT

In December 2009, the American Society for Veterinary Clinical Pathology (ASVCP) Quality Assurance and Laboratory Standards committee published the updated and peer-reviewed ASVCP Quality Assurance Guidelines on the Society's website. These guidelines are intended for use by veterinary diagnostic laboratories and veterinary research laboratories that are not covered by the US Food and Drug Administration Good Laboratory Practice standards (Code of Federal Regulations Title 21, Chapter 58). The guidelines have been divided into 3 reports: (1) general analytical factors for veterinary laboratory performance and comparisons; (2) hematology, hemostasis, and crossmatching; and (3) clinical chemistry, cytology, and urinalysis. This particular report is one of 3 reports and documents recommendations for control of preanalytical, analytical, and postanalytical factors related to urinalysis, cytology, and clinical chemistry in veterinary laboratories and is adapted from sections 1.1 and 2.2 (clinical chemistry), 1.3 and 2.5 (urinalysis), 1.4 and 2.6 (cytology), and 3 (postanalytical factors important in veterinary clinical pathology) of these guidelines. These guidelines are not intended to be all-inclusive; rather, they provide minimal guidelines for quality assurance and quality control for veterinary laboratory testing and a basis for laboratories to assess their current practices, determine areas for improvement, and guide continuing professional development and education efforts.


Subject(s)
Clinical Chemistry Tests/veterinary , Cytological Techniques/veterinary , Pathology, Clinical/organization & administration , Specimen Handling/veterinary , Urinalysis/veterinary , Veterinary Medicine/organization & administration , Animals , Clinical Chemistry Tests/methods , Clinical Chemistry Tests/standards , Cytological Techniques/standards , Laboratories/standards , Pathology, Clinical/standards , Quality Assurance, Health Care/standards , Quality Control , Societies, Scientific/standards , Species Specificity , Specimen Handling/standards , Urinalysis/standards , Veterinary Medicine/standards
5.
Vet Clin Pathol ; 39(3): 264-77, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21054473

ABSTRACT

Owing to lack of governmental regulation of veterinary laboratory performance, veterinarians ideally should demonstrate a commitment to self-monitoring and regulation of laboratory performance from within the profession. In response to member concerns about quality management in veterinary laboratories, the American Society for Veterinary Clinical Pathology (ASVCP) formed a Quality Assurance and Laboratory Standards (QAS) committee in 1996. This committee recently published updated and peer-reviewed Quality Assurance Guidelines on the ASVCP website. The Quality Assurance Guidelines are intended for use by veterinary diagnostic laboratories and veterinary research laboratories that are not covered by the US Food and Drug Administration Good Laboratory Practice standards (Code of Federal Regulations Title 21, Chapter 58). The guidelines have been divided into 3 reports on 1) general analytic factors for veterinary laboratory performance and comparisons, 2) hematology and hemostasis, and 3) clinical chemistry, endocrine assessment, and urinalysis. This report documents recommendations for control of general analytical factors within veterinary clinical laboratories and is based on section 2.1 (Analytical Factors Important In Veterinary Clinical Pathology, General) of the newly revised ASVCP QAS Guidelines. These guidelines are not intended to be all-inclusive; rather, they provide minimum guidelines for quality assurance and quality control for veterinary laboratory testing. It is hoped that these guidelines will provide a basis for laboratories to assess their current practices, determine areas for improvement, and guide continuing professional development and education efforts.


Subject(s)
Guidelines as Topic , Laboratories/standards , Pathology, Veterinary/standards , Animals , Calibration/standards , Indicators and Reagents/standards , Manuals as Topic/standards , Medical Laboratory Personnel/standards , Quality Control , Reproducibility of Results , Societies, Scientific/standards
6.
AJR Am J Roentgenol ; 191(3): 664-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18716092

ABSTRACT

OBJECTIVE: The purpose of our study was to determine the efficacy of contrast-enhanced CT in detecting a thickened endometrium. We used transvaginal sonography as the reference standard. MATERIALS AND METHODS: Between March 2005 and January 2007, data from 259 patients (mean age, 47 years; age range, 18-90 years) who underwent transvaginal sonography and contrast-enhanced CT of the pelvis were analyzed retrospectively. The endometrium was quantitatively measured in millimeters on sonography. On CT it was qualitatively categorized as normal, thickened, indeterminate, or not visualized and compared with the sonography findings and original radiology reports. When the endometrium was indeterminate (thickened or triangular in shape on axial images), sagittal reconstructions were performed for final categorization. Two reviewers evaluated the CT scans and sonograms jointly with differences resolved by consensus. Kappa, Wilcoxon's rank sum test, and intraclass correlation statistics were derived. RESULTS: The overall sensitivity and specificity of CT in detecting the thickened endometrium was 53.1% and 93.5%, respectively, relative to transvaginal sonography. The positive and negative predictive values were 66.7% and 89.1%, respectively. Kappa, the statistical measure of agreement between CT and sonography data, was 0.5049. All cases of a triangular endometrium were normal in size on sagittal reconstruction images. CONCLUSION: Routine pelvic CT correctly identifies a normal endometrium in most patients. Sagittal reconstruction images are helpful to further evaluate the endometrium on CT in cases with a prominent or triangular endometrium because these are often related to uterine version. CT is relatively insensitive in detecting the thickened endometrium but better able to identify gross rather than subtle thickening, which must be further characterized by transvaginal sonography.


Subject(s)
Endometrium/diagnostic imaging , Iohexol/analogs & derivatives , Postmenopause , Premenopause , Tomography, X-Ray Computed/methods , Uterine Diseases/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Contrast Media , Female , Humans , Middle Aged
7.
J Hum Lact ; 21(3): 320-6, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16113020

ABSTRACT

This article reports on breastfeeding intentions of Hispanic and black women by country of origin (continental US born or foreign born) in a low-income population that has experienced demographic shifts. Data were derived from prenatal interviews with 382 women from 2 community clinics. Primary outcome measures were intentions to formula feed, breastfeed, or formula and breastfeed. Foreign-born women were significantly more likely to intend to only breastfeed (42% vs 24% for continental US born, P < .05). In multivariate analyses, country of origin and having breastfed a previous child were the only significant predictors of breastfeeding intention. In contrast to previous work, black (non-Hispanic) and Hispanic women's breastfeeding plans were similar. This finding coincides with dramatic increases in the numbers of blacks from West Indian countries-where breastfeeding is the norm-in the study locale.


Subject(s)
Breast Feeding/ethnology , Breast Feeding/statistics & numerical data , Emigration and Immigration , Ethnicity , Adult , Black People , Female , Hispanic or Latino , Humans , Infant, Newborn , United States
8.
Article in English | MEDLINE | ID: mdl-15358301

ABSTRACT

3'-Azido-3'-deoxythymidine (AZT, Zidovudine) has been effectively used for HIV infection treatment. It inhibits virus reproduction through viral reverse transcriptase inhibition. However, the side effects of this anti-retroviral drug might be cumulative, particularly in its effects on the patients' DNA. As a nucleoside analogue, AZT might incorporate into hosts' DNA, and then form DNA adducts. This may result in potential long-term risks of mutagenesis in AIDS patients who received therapy. In this feasibility study, a (32)P-post-labeling thin-layer chromatography (TLC) assay is successfully used to measure AZT-DNA analogue and adducts formed in peripheral blood leukocytes of AZT treated patients. There are DNA analogue/adducts measured in all four AZT treated patients' DNA specimens. This assay is reliable with the significant coefficient of correlation in both intra-assay (r = 0.8761, P = 0.0001) and inter-assay (r = 0.8761, P = 0.0001).


Subject(s)
DNA Adducts/drug effects , HIV Infections/metabolism , Leukocytes/metabolism , Zidovudine/pharmacology , Animals , Autoradiography , Cattle , Chromatography, Thin Layer , DNA Adducts/analysis , DNA Fingerprinting , DNA Repair/drug effects , Densitometry , Feasibility Studies , Humans , Isotope Labeling , Lasers , Leukocytes/drug effects , Phosphorus Radioisotopes
9.
J Perinatol ; 22(1): 78-81, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11840248

ABSTRACT

The health benefits of breast-feeding are well documented, as are the positive effects of breast-feeding promotion interventions. There is a clear dose-response relationship between breast-feeding and infant health in the first year of life, and beyond. Further, nearly all breast-feeding promotion interventions improve--at least minimally--breast-feeding initiation and duration rates. However, the extent to which the costs of such interventions might be offset by the potential health care cost savings during the infant's first year of life has not been examined. From a health policy perspective, such an economic analysis is indicated.


Subject(s)
Breast Feeding , Health Promotion , Health Care Costs , Health Policy , Humans , Infant , Infant Welfare , Public Health
SELECTION OF CITATIONS
SEARCH DETAIL
...